Back to today’s briefing

Story perspectives

CTC Market Soars Amid Rising Cancer Rates and Tech Advances

10/9/2025

48 9

Summary

Story summary

The Circulating Tumor Cells (CTC) market is expanding rapidly due to rising cancer rates and demand for non-invasive diagnostics.
Advances in microfluidics and AI are boosting detection sensitivity and specificity, strengthening CTCs in personalized medicine.
North America leads the market with high healthcare spending and innovative research, focusing on breast and prostate cancers, while costs and regulatory hurdles challenge access.

1 of 1

Story summary

The Circulating Tumor Cells (CTC) market is expanding rapidly due to rising cancer rates and demand for non-invasive diagnostics.
Advances in microfluidics and AI are boosting detection sensitivity and specificity, strengthening CTCs in personalized medicine.
North America leads the market with high healthcare spending and innovative research, focusing on breast and prostate cancers, while costs and regulatory hurdles challenge access.